Avita Medical Ltd (RCEL)

[Fitz1030]

That is always a risk, but I wouldn't trade based on that speculation alone (too many signs point to continued Recell adoption/sales growth).

Case in point, all you have to do is look at the chart for the two weeks prior to the Q3 earnings release. We went from a high of $9.80 to a low of $8.10 the day before earnings came out. Based on that price action alone, you could have assumed insiders were selling before a bad earnings report. Q3 earnings came out on 10/31 and they were great (sales were up 60% Q/Q). The stock rallied back up to $9.80 that following week. I'm glad I didn't rush to conclusions from price action alone and sell.